16-30 of 200
How Delayed Diagnosis Can Affect Psoriatic Arthritis Patients
Living RheumHow Delayed Diagnosis Can Affect Psoriatic Arthritis Patients
Philip Mease, MD, MACR
Improving Psoriatic Arthritis Diagnosis: The Role of Education
Living RheumImproving Psoriatic Arthritis Diagnosis: The Role of Education
Philip Mease, MD, MACR
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Living RheumThe Potential Role of GLP-1s in Psoriatic Arthritis Management
Philip Mease, MD, MACR
Recognizing Loss of Treatment Response in Psoriatic Arthritis
Living RheumRecognizing Loss of Treatment Response in Psoriatic Arthritis
Philip Mease, MD, MACR
Emerging Therapeutic Approaches for Psoriatic Arthritis
Living RheumEmerging Therapeutic Approaches for Psoriatic Arthritis
Philip Mease, MD, MACR
SGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Living RheumSGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
- advertisement
Targeting Celastrol Delivery to Inflamed Joints in Rheumatoid Arthritis
Living RheumTargeting Celastrol Delivery to Inflamed Joints in Rheumatoid Arthritis
How Obesity Influences Psoriatic Arthritis Risk and Outcomes
Living RheumHow Obesity Influences Psoriatic Arthritis Risk and Outcomes
Philip Mease, MD, MACR
Advancing Bone Health: Key Insights from ISO 2026
Boning Up on OsteoporosisAdvancing Bone Health: Key Insights from ISO 2026
Marshall Miller
Ami R. Patel
Avery H. LaChance, MD, MPH, FAAD
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Living RheumIL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Understanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
Living RheumUnderstanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
- advertisement
The Cardiovascular Dimension of Psoriatic Arthritis
Living RheumThe Cardiovascular Dimension of Psoriatic Arthritis
Early Arthritis Insights from the CATCH Cohort
Living RheumEarly Arthritis Insights from the CATCH Cohort
Louis Bessette MD, FRCP(C), MSc
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Living RheumSpot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD